Markets:

Overview

News

Currencies

International

Treasuries

GeneDx Holdings Corp. - Class A Common Stock (NQ:WGS)

135.35 -4.82 (-3.44%)

Streaming Delayed Price Updated: 4:00 PM EST, Dec 23, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about GeneDx Holdings Corp. - Class A Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

The Great Rotation: Small-Caps Break All-Time Highs as Investors Pivot from Mega-Tech

December 19, 2025

NEW YORK — In a dramatic shift that has redefined the market landscape of 2025, small-cap stocks have surged to historic levels, signaling what many analysts are calling the "Great Rotation." On...

Via MarketMinute

The Great Rotation: Why the Russell 2000 is Finally Outpacing the Giants in Late 2025

December 18, 2025

As of mid-December 2025, the long-awaited "Great Rotation" in the financial markets has shifted from a theoretical prediction to a dominant reality. For the better part of the last three years,...

Via MarketMinute

Topics Artificial Intelligence Bonds Economy

Earnings Scheduled For October 28, 2025 ↗

October 28, 2025

Via Benzinga

GeneDx Hldgs's Earnings: A Preview ↗

October 27, 2025

Via Benzinga

GeneDx Holdings Corp. (NASDAQ:WGS) Passes Minervini Trend Template and High-Growth Momentum Screen ↗

December 17, 2025

GeneDx (WGS) stock passes a strict growth screen, combining Minervini's strong trend template with accelerating earnings and sales fundamentals.

Via Chartmill

JAMA (Journal of the American Medical Association) Recognizes GUARDIAN Newborn Genomic Screening Study Among Its Research of the Year

December 15, 2025

From GeneDx

Via Business Wire

GeneDX CEO Sells 2,158 Shares After 84% One-Year Bump ↗

December 09, 2025

The AI-powered genetic-testing company has been a strong performer. The CEO's recent move had more to do with accounting than conviction.

Via The Motley Fool

Topics Artificial Intelligence Regulatory Compliance

Option Care Health Bring Home Hefty Share Price Gains; Earns RS Rating Upgrade ↗

November 26, 2025

The upgraded 74 RS Rating shows that the Chicago area-based home health care firm tops more than 70% of stocks for price performance.

Via Investor's Business Daily

GeneDx Holdings Corp (NASDAQ:WGS) Presents a Strong Case for Growth Momentum and Technical Breakout ↗

November 20, 2025

GeneDx (WGS) shows explosive earnings growth of 1,125% and strong technicals, presenting a high-growth momentum and breakout opportunity.

Via Chartmill

Is Teladoc Stock a Buy After Oracle Investment Management Upped Its Stake? ↗

November 19, 2025

The investment company displayed confidence in Teladoc's growth potential by expanding its holdings in the stock.

Via The Motley Fool

6 Healthcare Stocks With Strong Upward Momentum ↗

November 18, 2025

Via Benzinga

BOSUN Sells All 70K GeneDx Holdings Corp. Shares—Should Investors Follow Suit? ↗

November 14, 2025

BOSUN Sells All 70K GeneDx Holdings Corp. Shares—Should Investors Follow Suit?

Via The Motley Fool

Topics Artificial Intelligence

BOSUN Sells All 70K GeneDx Holdings Corp. Shares—Should Investors Follow Suit? ↗

November 12, 2025

BOSUN Sells All 70K GeneDx Holdings Corp. Shares—Should Investors Follow Suit?

Via The Motley Fool

Topics Artificial Intelligence

Artificial Intelligence (AI) Stock Scores Vote of Confidence From Asset Manager, According to Recent Filing ↗

November 11, 2025

Artificial Intelligence (AI) Stock Scores Vote of Confidence From Asset Manager, According to Recent Filing

Via The Motley Fool

Topics Artificial Intelligence Regulatory Compliance

GeneDx to Showcase Advancements in Gene-Disease Discovery, Long-Read Sequencing and More at National Society of Genetic Counselors (NSGC) 2025 Annual Meeting

November 06, 2025

From GeneDx

Via Business Wire

GeneDx Holdings Corp (NASDAQ:WGS) Emerges as a Premier Growth and Momentum Stock ↗

November 05, 2025

GeneDx (WGS) stock aligns with growth & momentum strategies, showing a powerful uptrend backed by explosive earnings growth and strong technical health.

Via Chartmill

GeneDx to Participate in Upcoming Investor Conferences

November 04, 2025

From GeneDx

Via Business Wire

What Does the Market Think About GeneDx Holdings Corp? ↗

October 31, 2025

Via Benzinga

GeneDx (WGS) Q3 2025 Earnings Call Transcript ↗

October 28, 2025

GeneDx (WGS) Q3 2025 Earnings Call Transcript

Via The Motley Fool

Topics Earnings

GeneDx Holdings Corp (NASDAQ:WGS) Q3 2025 Earnings Beat Estimates and Drive Stock Higher ↗

October 28, 2025

GeneDx Q3 2025 earnings crush estimates with 52% revenue growth. Strong exome/genome test demand and raised 2025 guidance fuel investor optimism.

Via Chartmill

Topics Earnings

GeneDx Reports Third Quarter 2025 Financial Results and Business Highlights

October 28, 2025

From GeneDx

Via Business Wire

Halper Sadeh LLC Encourages GeneDx Holdings Corp. Shareholders to Contact the Firm to Discuss Their Rights

October 24, 2025

From Halper Sadeh LLC

Via Business Wire

GeneDx Showcases Leadership in Genomic Newborn Screening at ICoNS 2025

October 22, 2025

From GeneDx

Via Business Wire

4 Analysts Assess GeneDx Holdings: What You Need To Know ↗

October 20, 2025

Via Benzinga

GeneDx Granted FDA Breakthrough Device Designation for its ExomeDx™ and GenomeDx™ Testing

October 20, 2025

From GeneDx

Via Business Wire

This WillScot Holdings Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday ↗

October 20, 2025

Via Benzinga

GeneDx Appoints Dr. Mimi Lee as Chief Precision Medicine Officer

October 14, 2025

From GeneDx

Via Business Wire

GeneDx Holdings Corp (NASDAQ:WGS) Presents a High-Growth Momentum and Technical Breakout Case ↗

October 14, 2025

GeneDx stock shows strong growth momentum with 600% EPS growth and a bullish technical setup, signaling a potential breakout for investors.

Via Chartmill

GeneDx to Partner with Florida’s Sunshine Genetics Network, Launching Nation’s First State-Backed Genomic Newborn Screening Program

October 13, 2025

From GeneDx

Via Business Wire

GeneDx to Launch Autism Partnership Program to Expand Access to Exome and Genome Testing, including Dedicated SHANK3 Program

October 09, 2025

From GeneDx

Via Business Wire

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.